FDA Inspection 1169285 — Pharmacyclics LLC

Pharmacyclics LLC — FEI 1000522932

The FDA completed an inspection of Pharmacyclics LLC on Apr 27, 2022 in South San Francisco, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 2 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Apr 27, 2022
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
South San Francisco, CA (United States)

Additional Details

Sponsor, Contract Research Organization

Citations

IDCFRDescription
745221 CFR 312.56(c)IND safety report
750721 CFR 312.52(a)Transfer of obligations